Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
T.ONC
Alternate Symbol(s):
ONCY
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune...
responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(196)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Apr 24, 2024 3:49pm
RE:The Calm Before the Storm.
Low volume is more likely do to folks waiting to see if this dead horse gets revived by some miracle.
(5836)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 24, 2024 12:12pm
RE:RE:RE:Breast cancer treatment: perspectives on the oncolytic virus
Employing biomarkers and surrogate endpoints in Orphan/Rare diseases, like in metatstatic breast cancer, result in smaller registration studies and more particularly opens the door for "
...more
Strong Q1 and Muscular Q2 Outlook for Cannabis Edibles Leader
posted May 26, 2024 9:00am by
Indiva Ltd
-
|
Gross revenue Q1 was $10.6 million, a 2.6% increase YOY as the company replaced over 50% of its net revenue from Wana’s shift to contract manufacturing and a regulatory change with its own core brands, namely Pearls gummies. Post Q1, April 2024 was a record month for net revenue, with growth driven by continued strength in Pearls, revenue from No Future gummies and Indiva Blips ...read more
(5836)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 24, 2024 12:11pm
RE:RE:Breast cancer treatment: perspectives on the oncolytic virus
Advancements in identifying predictive biomarkers for treatment response remain also urgent. Identifying biomarkers associated with the efficacy of OVs can aid in patient stratification, ensuring
...more
(400)
•••
Peladawn
X
View Profile
View Bullboard History
Post by
Peladawn
on Apr 24, 2024 11:24am
The Calm Before the Storm.
Volume has dropped way off, and that usually means that investors are watching and waiting for the next catalyst.... I decided to go back over the last years news releases, and the gaps between those
...more
(5836)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 24, 2024 11:13am
RE:RE:Breast cancer treatment: perspectives on the oncolytic virus
https://stockhouse.com/companies/bullboard/t.onc/oncolytics-biotech-inc?postid=36005001
(479)
•••
Lesalpes29
X
View Profile
View Bullboard History
Post by
Lesalpes29
on Apr 24, 2024 11:03am
Thumb's up
For your last post Azzak34. Roche let's go!
(5836)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 24, 2024 10:53am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
According to Spherical Insights Research the Global Breast Cancer Market Size is expected to reach USD $85.5 Billion by 2032, at a CAGR of 10.3% during the forecast period 2022 to 2032.
...more
(5836)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 24, 2024 10:44am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
According to the Evaluate 2024 report, the top 10 most valuable orphan drugs will together collect more than $57 billion in 2028. That top 10 list has had a bit of a shakeup since Evaluate’s last
...more
(5836)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 24, 2024 10:35am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
According to a new Evaluate 2024 analysis the orphan drug category is set to pick up $185 billion in sales this year and some $270 billion by 2028. While the obesity market is
...more
(5836)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 24, 2024 8:33am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
Roche cull ..."The drugmaker needs to terminate some programs to free up cash to invest in accelerating “a number of projects that have a high likelihood to succeed and have a huge patient impact
...more
(1409)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Apr 24, 2024 6:12am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
https://www.fiercebiotech.com/biotech/roches-pipeline-rethink-hits-20-new-molecules-cancer-candidates-join-discard-pile
(48)
•••
spesestsemper
X
View Profile
View Bullboard History
Comment by
spesestsemper
on Apr 23, 2024 7:32pm
RE:short interest
Short Sale Trading Statistics and Reports | IIROC I think i found the Canadian market short position . According too this site as of april 15 - the short position was 305710 . just click
...more
(5836)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 23, 2024 6:34pm
RE:RE:RE:RE:RE:RE:EU Legislative proposals aims to expedite new medicines
And Yes ... you "Mo" are part of the Three Stooges - Larry, Mo, and Curly Joe.
(5836)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 23, 2024 6:22pm
RE:RE:RE:RE:EU Legislative proposals aims to expedite new medicines
As of April 11, 2024 we now have the various international regulatory bodies "pulling" in the same direction for the potential of ONCY's pelareorep's Accelerated
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >